Overcoming Data Bottlenecks in Genomic Pathogen Surveillance.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
01 12 2021
Historique:
entrez: 1 12 2021
pubmed: 2 12 2021
medline: 16 3 2022
Statut: ppublish

Résumé

Performing whole genome sequencing (WGS) for the surveillance of antimicrobial resistance offers the ability to determine not only the antimicrobials to which rates of resistance are increasing, but also the evolutionary mechanisms and transmission routes responsible for the increase at local, national, and global scales. To derive WGS-based outputs, a series of processes are required, beginning with sample and metadata collection, followed by nucleic acid extraction, library preparation, sequencing, and analysis. Throughout this pathway there are many data-related operations required (informatics) combined with more biologically focused procedures (bioinformatics). For a laboratory aiming to implement pathogen genomics, the informatics and bioinformatics activities can be a barrier to starting on the journey; for a laboratory that has already started, these activities may become overwhelming. Here we describe these data bottlenecks and how they have been addressed in laboratories in India, Colombia, Nigeria, and the Philippines, as part of the National Institute for Health Research Global Health Research Unit on Genomic Surveillance of Antimicrobial Resistance. The approaches taken include the use of reproducible data parsing pipelines and genome sequence analysis workflows, using technologies such as Data-flo, the Nextflow workflow manager, and containerization of software dependencies. By overcoming barriers to WGS implementation in countries where genome sampling for some species may be underrepresented, a body of evidence can be built to determine the concordance of antimicrobial sensitivity testing and genome-derived resistance, and novel high-risk clones and unknown mechanisms of resistance can be discovered.

Identifiants

pubmed: 34850839
pii: 6447014
doi: 10.1093/cid/ciab785
pmc: PMC8634317
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S267-S274

Subventions

Organisme : Medical Research Council
ID : MR/L00464X/1
Pays : United Kingdom

Investigateurs

Harry Harste (H)
Mihir Kekre (M)
Dawn Muddyman (D)
Ben Taylor (B)
Nicole Wheeler (N)
Sophia David (S)
Alejandra Arevalo (A)
Maria Fernanda Valencia (M)
Erik C D Osma Castro (ECD)
Geetha Nagaraj (G)
Vandana Govindan (V)
Akshata Prabhu (A)
D Sravani (D)
M R Shincy (MR)
Steffimole Rose (S)
Kundur N Ravishankar (KN)
Anderson O Oaikhena (AO)
Jolaade J Ajiboye (JJ)
Erkison Ewomazino Odih (E)
Marietta L Lagrada (ML)
Polle Krystle V Macaranas (PKV)
Agnettah M Olorosa (AM)
Elmer M Herrera (EM)
Ali Molloy (A)
John Stelling (J)
Carolin Vegvari (C)

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

Nat Commun. 2021 May 17;12(1):2879
pubmed: 34001879
J Clin Microbiol. 2019 Feb 27;57(3):
pubmed: 30381421
Clin Microbiol Infect. 2018 Apr;24(4):355-360
pubmed: 29117578
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
Nat Biotechnol. 2020 Mar;38(3):276-278
pubmed: 32055031
Front Public Health. 2019 Sep 04;7:242
pubmed: 31552211
PeerJ. 2019 May 31;7:e6995
pubmed: 31183253
Genome Med. 2021 Apr 19;13(1):61
pubmed: 33875000
Methods Mol Biol. 2019;1910:723-745
pubmed: 31278683
Microb Genom. 2016 Nov 30;2(11):e000093
pubmed: 28348833
Nat Rev Genet. 2014 Jan;15(1):49-55
pubmed: 24281148
Clin Microbiol Infect. 2017 Jan;23(1):2-22
pubmed: 27890457
PLoS Comput Biol. 2018 Jun 14;14(6):e1006144
pubmed: 29902176
PLoS One. 2016 Jun 21;11(6):e0157718
pubmed: 27327771
Clin Infect Dis. 1997 Jan;24 Suppl 1:S157-68
pubmed: 8994799
PLoS One. 2017 May 11;12(5):e0177459
pubmed: 28494014
Microb Genom. 2020 Feb;6(2):
pubmed: 32048983
N Engl J Med. 2019 Dec 26;381(26):2569-2580
pubmed: 31881145
Nat Commun. 2020 Jun 1;11(1):2719
pubmed: 32483195
Nat Biotechnol. 2017 Apr 11;35(4):316-319
pubmed: 28398311
J Antimicrob Chemother. 2020 Nov 1;75(11):3099-3108
pubmed: 32658975
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339

Auteurs

Ayorinde O Afolayan (AO)

Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Oyo State, Nigeria.

Johan Fabian Bernal (JF)

Colombian Integrated Program for Antimicrobial Resistance Surveillance, Centro de Investigatión Tibaitatá, Corporación Colombiana de Investigación Agropecuaria, Tibaitatá, Mosquera, Cundinamarca, Colombia.

June M Gayeta (JM)

Antimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, Philippines.

Melissa L Masim (ML)

Antimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, Philippines.

Varun Shamanna (V)

Central Research Laboratory, Kempegowda Institute of Medical Sciences, Bengaluru, India.

Monica Abrudan (M)

Centre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

Khalil Abudahab (K)

Centre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

Silvia Argimón (S)

Centre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

Celia C Carlos (CC)

Antimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, Philippines.

Sonia Sia (S)

Antimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, Philippines.

Kadahalli L Ravikumar (KL)

Central Research Laboratory, Kempegowda Institute of Medical Sciences, Bengaluru, India.

Iruka N Okeke (IN)

The NIHR Global Health Research Unit for the Genomic Surveillance of Antimicrobial Resistance.

Pilar Donado-Godoy (P)

Colombian Integrated Program for Antimicrobial Resistance Surveillance, Centro de Investigatión Tibaitatá, Corporación Colombiana de Investigación Agropecuaria, Tibaitatá, Mosquera, Cundinamarca, Colombia.

David M Aanensen (DM)

Centre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

Anthony Underwood (A)

Centre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH